Antifungal activity and influence of propolis against germ tube formation as a critical virulence attribute by clinical isolates of Candida albicans;Activité antifongique et l'influence de propolis contre la formation de germ tube, facteur de virulence critique d'isolats cliniques de Candida albicans

Journal de Mycologie Medicale

Volumn 26, Issue 4, 2016, Pages 298-305

  Haghdoost, N S ^a   Salehi, T Z ^a   Khosravi, A ^a   Sharifzadeh, A ^a  

^a UNIVERSITY OF TEHRAN   (Iran)

Author keywords

C. albicans; Germ tube formation; Propolis; Virulence factor

Indexed keywords

ALIPHATIC CARBOXYLIC ACID; AROMATIC CARBOXYLIC ACID; PHENOL DERIVATIVE; POLYCYCLIC AROMATIC HYDROCARBON DERIVATIVE; PROPOLIS; SUGAR; ANTIFUNGAL AGENT; FLUCONAZOLE;

ANTIFUNGAL ACTIVITY; ARTICLE; BROTH DILUTION; CANDIDA ALBICANS; CONTROLLED STUDY; FUNGAL SPORE GERMINATION; FUNGAL STRAIN; FUNGAL VIRULENCE; FUNGUS ISOLATION; GERM TUBE FORMATION; HUMAN; MASS FRAGMENTOGRAPHY; MINIMUM FUNGICIDAL CONCENTRATION; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; CANDIDIASIS; DRUG EFFECTS; FEMALE; FUNGUS HYPHAE; GROWTH, DEVELOPMENT AND AGING; ISOLATION AND PURIFICATION; MALE; MICROBIAL SENSITIVITY TEST; MICROBIOLOGY; PATHOGENICITY; VIRULENCE;

ANTIFUNGAL AGENTS; CANDIDA ALBICANS; CANDIDIASIS; FEMALE; FLUCONAZOLE; GAS CHROMATOGRAPHY-MASS SPECTROMETRY; HUMANS; HYPHAE; MALE; MICROBIAL SENSITIVITY TESTS; PROPOLIS; VIRULENCE;

EID: 84999266649     PISSN: 11565233     EISSN: 17730449     Source Type: Journal    
DOI: 10.1016/j.mycmed.2015.11.004     Document Type: Article

References (27)

1. [1] Abdulkhani, A., Hosseinzadeh, J., Ashori, A., Esmaeeli, H., Evaluation of the antibacterial activity of cellulose nanofibers/polylactic acid composites coated with ethanolic extract of propolis. Polym Composit, 2015.
2. [2] Budzynska, A., Sadowska, B., Wieckowska-Szakiel, M., Rozalska, B., Enzymatic profile, adhesive and invasive properties of Candida albicans under the influence of selected plant essential oils. Acta Biochim Pol 61 (2014), 115–121.
3. [3] Cannon, R.D., Chaffin, W.L., Oral colonization by Candida albicans. Crit Rev Oral Biol Med 10 (1999), 359–383.
4. [4] Dalben-Dota, K.F., Faria, M.G., Bruschi, M.L., Pelloso, S.M., Lopes-Consolaro, M.E., Svidzinski, T.I., Antifungal activity of propolis extract against yeasts isolated from vaginal exudates. J Altern Complement Med 16 (2010), 285–290.
5. [5] D'auria, F.D., Tecca, M., Scazzocchio, F., Renzini, V., Strippoli, V., Effect of propolis on virulence factors of Candida albicans. J Antimicrob Chemother 15 (2003), 454–460.
6. [6] D'auria, F.D., Tecca, M., Strippoli, V., Salvatore, G., Battinelli, L., Mazzanti, G., Antifungal activity of Lavandula angustifolia essential oil against Candida albicans yeast and mycelial form. Med Mycol 43 (2005), 391–396.
7. [7] Fisher, J.F., Kavanagh, K., Sobel, J.D., Kauffman, C.A., Newman, C.A., Candida urinary tract infection: pathogenesis. Clin Infect Dis 52 (2011), 437–451.
8. [8] Herrera, C.L., Alvear, M., Barrientos, L., Montenegro, G., Salazar, L.A., The antifungal effect of six commercial extracts of Chilean propolis on Candida spp. Cience Investig Agrar 37 (2010), 75–84.
9. [9] Khan, M.S., Ahmad, I., Cameotra, S.S., Botha, F., Sub-MICs of Carum copticum and Thymus vulgaris influence virulence factors and biofilm formation in Candida spp. BMC Complement Altern Med, 14, 2014, 337.
10. [10] Marcucci, M.C., Propolis: chemical composition, biological properties and therapeutic activity. Apidologie 26 (1995), 83–99.
11. [11] Marcucci, M.C., Ferreres, F., Garcıa-Viguera, C., Bankova, V.S., De Castro, S.L., Dantas, A.P., et al. Phenolic compounds from Brazilian propolis with pharmacological activities. J Ethnopharmacol 74 (2001), 105–112.
12. [12] Matsumoto, H., Nagao, J.I., Cho, T., Kodama, J., Evaluation of pathogenicity of Candida albicans in germination-ready states using a silkworm infection model. Med Mycol 54 (2013), 131–140.
13. [13] Mayer, F.L., Wilson, D., Hube, B., Candida albicans pathogenicity mechanisms. Virulence 4 (2010), 119–128.
14. [14] Naicker, S.D., Patel, M., Dodonaea viscosa var. angustifolia inhibits germ tube and biofilm formation by C. albicans. J Evid Based Compl Altern Med, 2013.
15. [15] Nailis, H., Kucharíková, S., Řičicová, M., Van Dijck, P., Deforce, D., Nelis, H., et al. Real-time PCR expression profiling of genes encoding potential virulence factors in Candida albicans biofilms: identification of model-dependent and -independent gene expression. BMC Microbiol, 10, 2010, 114.
16. [16] Oliveira, A.C.P., Shinobu, C.S., Longhini, R., Franco, S.L., Svidzinski, T.I.E., Antifungal activity of propolis extract against yeasts isolated from onychomycosis lesions. Mem Inst Oswaldo Cruz 101 (2006), 493–497.
17. [17] Ota, C., Unterkircher, C., Fantinato, V., Shimizu, M.T., Antifungal activity of propolis on different species of Candida. Mycoses 44 (2001), 375–378.
18. [18] Ramos, A.F.N., Miranda, J.L., Propolis: a review of its anti-inflammatory and healing actions. J Venom Anim Toxins 13 (2007), 697–710.
19. [19] Sahinler, N., Kaftanoglu, O., Natural product propolis: chemical composition. Nat Prod Res 19 (2005), 183–188.
20. [20] Sawaya, A.C., Palma, A.M., Caetano, F.M., Marcucci, M.C., da Silva Cunha, I.B., Araujo, C.E.P., et al. Comparative study of in vitro methods used to analyse the activity of propolis extracts with different compositions against species of Candida. Lett Appl Microbiol 35 (2002), 203–207.
21. [21] Shokri, H., Khosravi, A.R., Yalfani, R., Antifungal efficacy of propolis against fluconazole-resistant Candida glabrata isolates obtained from women with recurrent vulvovaginal candidiasis. Int J Gynaecol Obstet 114 (2011), 158–159.
22. [22] Takaisi-Kikuni, N.B., Schilcher, H., Electron microscopic and microcalorimetric investigations of the possible mechanism of the antibacterial action of a defined propolis provenance. Planta Med 60 (1994), 222–227.
23. [23] Tsang, P.W.K., Bandara, H.M., Fong, W.P., Purpurin suppresses Candida albicans biofilm formation and hyphal development. PLoS One, 7, 2012, e50866.
24. [24] Villar, C.C., Kashleva, H., Dongari-Bagtzoglou, A., Role of Candida albicans polymorphism in interactions with oral epithelial cells. Oral Microbial Immun 19 (2014), 262–269.
25. [25] Wayne, P.A., Clinical and Laboratory Standards Institute (CLSI). Reference method for broth dilution antifungal susceptibility testing of yeasts: approved standard, document M27-A3. CLSI 28 (2008), 6–12.
26. [26] White, T.C., Holleman, S., Dy, F., Mirels, L.F., Stevens, D.A., Resistance mechanisms in clinical isolates of Candida albicans. Antimicrob Agents Chemother 46 (2002), 1704–1713.
27. [27] Yarfani, R., Khosravi, A.R., Shokri, H., The antifungal activity of Iranian propolis samples against fluconazole-resistant Candida albicans strains isolated from HIV+ patients with oropharyngeal candidiasis. J ApiProd ApiMed Sci 2 (2010), 161–166.